- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT06905470
De effecten van excentriek in vergelijking met standaardsterkte -training in rehabilitatie van primaire ruggenmergletsel (KREHA3)
De effecten van excentriek in vergelijking met standaardsterkte training in primaire ruggenmergletselrevalidatie - een gerandomiseerde gerandomiseerde gecontroleerde proefonderzoek
The goal of this clinical trial is to assess the effects of eccentric arm-crank (KREHA) training compared to standard clinical routine strength (STAN) training in individuals undergoing primary spinal cord injury (SCI) rehabilitation.
The main questions this trail aims to answer are:
- what are the effects of the training on upper body strength, aerobic performance, muscle volume, functional independence, and health-related quality of life?
- is the KREHA training feasible to implement into the rehabilitation routine?
Participants will:
- perform either 20 KREHA sessions or 20 STAN sessions within 12 weeks
- perform a test battery to collect data on training effects before (pretest) and after (posttest) the study intervention
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Studietype
Inschrijving (Geschat)
Fase
- Niet toepasbaar
Contacten en locaties
Studiecontact
- Naam: Fabian Ammann, MSc
- Telefoonnummer: +41419396624
- E-mail: fabian.ammann@paraplegie.ch
Studie Contact Back-up
- Naam: Anneke Hertig-Godeschalk, PhD
- Telefoonnummer: +414 9396603
- E-mail: anneke.hertig@paraplegie.ch
Studie Locaties
-
-
Canton of Lucerne
-
Nottwil, Canton of Lucerne, Zwitserland, 6207
- Swiss Paraplegic Centre
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- 18 years or older.
- informed consent as confirmed per signature.
- traumatic or disease-related SCI.
- participating in the routine strength training program during primary SCI rehabilitation at the study center (generally this is initiated around one month after SCI onset).
- wheelchair dependency during activities of daily living, defined by a score of 0-2 in the SCIM subsection regarding "Mobility in the house".
- passed sports medical assessment and having sufficient biceps/triceps function to perform arm-crank training, as determined by an experienced sports medicine physician
Exclusion Criteria:
- inflammatory or neurodegenerative diseases (including multiple sclerosis or Guillain-Barré syndrome).
- comorbidities or other health issues that may interfere with study participation, inability or contraindications to undergo the investigated intervention.
- MRI contraindications (magnetic metal parts or electronic implants such as pacemakers in the body).
- pregnancy (anamnestic).
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Ondersteunende zorg
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Eccentric arm-crank (KREHA) training
The eccentric training intervention consists of 20 training sessions performed on a symmetric arm-crank (Krafttraining mittels exzentrischer Handkurbel, KREHA) device. The training sessions have a duration of approximately 30 min and will be completed within twelve weeks, with a maximum of three sessions per week. |
20 eccentric resistance training sessions will be performed on a symmetric arm-crank ergometer in a supine position. |
|
Actieve vergelijker: Standard clinical routine strength (STAN) training
The standard strength training intervention consists of a total of 20 training sessions at the gym of the study center, performed following clinical routine procedures. The training sessions have a duration of approximately 60 min and will be completed within twelve weeks, with around three sessions per week. |
The regular strength training intervention consists of a total of 20 training sessions at the gym of the study center, performed following clinical routine procedures. |
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Upper body strength
Tijdsspanne: < 1 week pre and 12 weeks post intervention start.
|
Change in upper body strength will be measured by a one-repetition maximum (1RM) bench press (in kg). The maximum amount of weight that can be pushed upwards for one repetition, while lying in a supine position on a weight training bench. |
< 1 week pre and 12 weeks post intervention start.
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Upper body strength
Tijdsspanne: < 1 week pre and 12 weeks post intervention start.
|
Change in upper body strength measured by a 1RM bench pull (in kg). The maximum amount of weight that can be pulled upwards for one repetition, while lying in a prone position on a weight training bench. |
< 1 week pre and 12 weeks post intervention start.
|
|
Handgrip strength
Tijdsspanne: < 1 week pre and 12 weeks post intervention start.
|
Change in maximum strength of three handgrip measurements (in kg) of both hands using a Jamar Handgrip Dynamometer. |
< 1 week pre and 12 weeks post intervention start.
|
|
Aerobic performance
Tijdsspanne: < 1 week pre and 12 weeks post intervention start.
|
Change in cardiopulmonary adaptations, measured by aerobic performance in an exercise test on a regular arm-crank ergometer. A ramp protocol starting at 20 Watt followed by 1 Watt / 6 sec increments to failure will be used. The following parameters will be evaluated during this aerobic endurance test: power at failure at the end of the test (in Watt), peak oxygen uptake during the test (in ml/kg/min), maximal heart rate (bpm) |
< 1 week pre and 12 weeks post intervention start.
|
|
Muscle volume
Tijdsspanne: < 1 week pre and 12 weeks post intervention start.
|
Magnetic resonance imaging (MRI) of relevant upper body muscles of the dominant upper arm and shoulder will be used to measure change in muscle volume. |
< 1 week pre and 12 weeks post intervention start.
|
|
Arm circumference
Tijdsspanne: < 1 week pre and 12 weeks post intervention start.
|
Change in arm circumference of the right and left lower and upper arm (in cm), will be used to estimate muscle volume. |
< 1 week pre and 12 weeks post intervention start.
|
|
Functioning during activities of daily living
Tijdsspanne: < 1 week pre and 12 weeks post intervention start.
|
Change in functioning during activities of daily living will be assessed by the Spinal Cord Independence Measure (SCIM) as extracted from clinical records. The SCIM total score ranges from 0-100, with higher scores indicating higher levels of functional independence. |
< 1 week pre and 12 weeks post intervention start.
|
|
Health-related quality of life
Tijdsspanne: < 1 week pre and 12 weeks post intervention start.
|
Change in health-related quality of life will be assessed using the Short Form Health Survey (SF-12). Weighted physical and mental component scores range from 0-100, with higher scores indicating better physical or mental health. |
< 1 week pre and 12 weeks post intervention start.
|
Andere uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Feasibility of the KREHA training (total number of training sessions)
Tijdsspanne: Throughout the intervention phase, week 0-12
|
Successful implementation of the KREHA training in the clinical routine, by assessing whether the 20 KREHA sessions are completed within 12 weeks. |
Throughout the intervention phase, week 0-12
|
|
Feasibility of the KREHA training progression (number of sessions adapted)
Tijdsspanne: Throughout the intervention phase, week 0-12
|
Feasibility of the KREHA training progression, by assessing how many training sessions needed to be adapted. |
Throughout the intervention phase, week 0-12
|
|
Feasibility of the KREHA training progression (power adaptation)
Tijdsspanne: Throughout the intervention phase, week 0-12
|
Feasibility of the KREHA training progression, by assessing how much the target power (in Watts) of a training session needed to be adapted compared to the initially planned progression. |
Throughout the intervention phase, week 0-12
|
Medewerkers en onderzoekers
Studie record data
Bestudeer belangrijke data
Studie start (Geschat)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- 2023-21
- SNCTP000006132 (Andere identificatie: Swiss National Clinical Trials Portal)
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .